Cerbios-Pharma showcasing chemical, ADC and biotechnology services at CPhI Worldwide 2018
Press Release | Cerbios-Pharma SA
SEPTEMBER 18, 2018
Lugano, Switzerland: – Pharmaceutical ingredient specialist Cerbios-Pharma SA (Cerbios) will showcase its advanced chemical and biological products and services at the landmark CPhI Worldwide event in Madrid in October.
The Cerbios stand at booth 9B48 will focus on the company’s sophisticated range of services and products: specialized Highly Active Pharmaceutical Ingredients (HAPIs), breakthrough recombinant-Urokinase (r-UK) and antibody drug conjugates (ADCs).
It will also present the all-embracing one-stop ADC solutions which cover the whole supply chain (from Antibodies up to bioconjugation and Cytotoxic Payloads).
The Cerbios team in Madrid, including CEO Dr. Gabriel Haering, will be reaching out to pharma companies, bio-ventures and start-ups involved in ADC and oncology to show its expertise in the payload and conjugation aspects of ADC technology.
Cerbios offers impressive cGMP capabilities such as handling toxic payloads, conjugation process development and manufacturing scale up.
Recently it has also deepened its core expertise in HAPIs, Probiotics and Recombinant proteins.
Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacturing of both chemical and biological APIs for its partners world-wide.
Cerbios’ is a global leading supplier of a portfolio of Generic APIs primarily used for the treatment of Respiratory and Dermatological disorders as well as in Oncology.
Exclusive, CDMO services are offered for the development and manufacturing of HPAIs as well as for Biological products including monoclonal antibodies, recombinant proteins, Antibody Drug Conjugates (ADCs) and pharma probiotics.
Cerbios provides full CMC support, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.
Since 2015, Cerbios has been a member of the ADC manufacture PROVEO™ consortium, forged with AGC Biologics of Denmark and with Germany’s Oncotec.
PROVEO can offer an ADCs end-to-end service from substance development through manufacturing to fill&finish.
About CPhI Worldwide 2018?
CPhI Worldwide is the flagship annual trade show for pharma ingredients and partner sourcing providing delegates and exhibitors opportunities to arrange face-to-face meetings with potential international pharmaceutical partners and collaborators and gain insights on latest industry trends.
Now in its 29th year, the 2018 event is a three-day event opening October 9 at IFEMA, Feria de Madrid, Spain, which last hosted the event in 2015. CPhI Worldwide 2018. CPhI Worldwide includes the co-located zoned exhibitions; ICSE Outsourcing solutions, P-MEC Machinery and Equipment and InnoPack pharmaceutical packaging events. Together, they are expected to attract a record 45,000 delegates along with 2,500 exhibiting companies from 153 countries.
New for 2018, the Expo will feature bioLIVE, a new specialized exhibition focusing on the biopharmaceutical industry.
The CPhI Pharma Awards, presented on the first evening of the conference, honor innovative companies and leaders in eight categories.
The CPhI series is staged by leading Global B2B Events Organizer and Publisher UBM Live More information at: https://www.cphi.com/europe/.
Chiara Brusadelli, Commercial Operations Assistant Manager, Cerbios-Pharma SA
Tel: +41 91 9856556